Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer

被引:24
作者
Durand, Nisha [1 ]
Borges, Sahra [1 ]
Storz, Peter [1 ]
机构
[1] Mayo Clin Jacksonville, Dept Canc Biol, Jacksonville, FL 32224 USA
关键词
Protein kinase D; PKD; Invasive breast cancer; Invasion; Multi-drug resistance; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; CELL-LINES; INTRACELLULAR REDISTRIBUTION; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; MOLECULAR-CLONING; TUMOR-SUPPRESSOR; DNA METHYLATION;
D O I
10.1007/s00018-015-2011-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein kinase D (PKD) family members, PKD1, PKD2 and PKD3 constitute a family of serine/threonine kinases that are essential regulators of cell migration, proliferation and protein transport. Multiple types of cancers are characterized by aberrant expression of PKD isoforms. In breast cancer PKD isoforms exhibit distinct expression patterns and regulate various oncogenic processes. In highly invasive breast cancer, the leading cause of cancer-associated deaths in females, the loss of PKD1 is thought to promote invasion and metastasis, while PKD2 and upregulated PKD3 have been shown to be positive regulators of proliferation, chemoresistance and metastasis. In this review, we examine the differential expression pattern, mechanisms of regulation and contributions made by each PKD isoform to the development and maintenance of invasive breast cancer. In addition, we discuss the potential therapeutic approaches for targeting PKD in this disease.
引用
收藏
页码:4369 / 4382
页数:14
相关论文
共 123 条
[1]   Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules [J].
Adair, Sara J. ;
Hogan, Kevin T. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (04) :589-601
[2]  
Akao Y, 2006, ONCOL REP, V16, P845
[3]   miRGen 2.0: a database of microRNA genomic information and regulation [J].
Alexiou, Panagiotis ;
Vergoulis, Thanasis ;
Gleditzsch, Martin ;
Prekas, George ;
Dalamagas, Theodore ;
Megraw, Molly ;
Grosse, Ivo ;
Sellis, Timos ;
Hatzigeorgiou, Artemis G. .
NUCLEIC ACIDS RESEARCH, 2010, 38 :D137-D141
[4]   Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells [J].
Alpsoy, Aktan ;
Gunduz, Ufuk .
TUMOR BIOLOGY, 2015, 36 (06) :4417-4426
[5]   Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival [J].
Auvinen, Paivi ;
Rilla, Kirsi ;
Tumelius, Ritva ;
Tammi, Markku ;
Sironen, Reijo ;
Soini, Ylermi ;
Kosma, Veli-Matti ;
Mannermaa, Arto ;
Viikari, Jukka ;
Tammi, Raija .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (02) :277-286
[6]   Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours [J].
Azoitei, Ninel ;
Pusapati, Ganesh Varma ;
Kleger, Alexander ;
Moeller, Peter ;
Kuefer, Rainer ;
Genze, Felicitas ;
Wagner, Martin ;
van Lint, Johan ;
Carmeliet, Peter ;
Adler, Guido ;
Seufferlein, Thomas .
GUT, 2010, 59 (10) :1316-1330
[7]   Protein kinase D-mediated phosphorylation at Ser99 regulates localization of p21-activated kinase 4 [J].
Bastea, Ligia I. ;
Doeppler, Heike ;
Pearce, Sarah E. ;
Durand, Nisha ;
Spratley, Samantha J. ;
Storz, Peter .
BIOCHEMICAL JOURNAL, 2013, 455 :251-260
[8]   Protein Kinase D1 Maintains the Epithelial Phenotype by Inducing a DNA-Bound, Inactive SNAI1 Transcriptional Repressor Complex [J].
Bastea, Ligia I. ;
Doeppler, Heike ;
Balogun, Bolanle ;
Storz, Peter .
PLOS ONE, 2012, 7 (01)
[9]   The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells [J].
Batlle, E ;
Sancho, E ;
Franci, C ;
Domínguez, D ;
Monfar, M ;
Baulida, J ;
de Herreros, AG .
NATURE CELL BIOLOGY, 2000, 2 (02) :84-89
[10]   Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116